| Scale |
Time period |
Experimental group(n=8) Mean±SD |
Control group (n=8) Mean±SD |
t-test |
ANCOVA |
| t |
P-value |
t |
P-value |
| WMFT |
Baseline |
2.68±0.71 |
2.62±0.82 |
0.16 |
0.88 |
|
|
| |
2 weeks |
3.33±0.94 |
3.49±0.90 |
-0.36 |
0.72 |
0.27 |
0.61 |
| |
4 weeks |
3.83±1.13 |
3.88±0.90 |
-0.10 |
0.92 |
0.03 |
0.87 |
| MAL(AOU) |
Baseline |
2.44±0.64 |
2.60±073 |
-0.47 |
0.64 |
|
|
| |
2 weeks |
2.92±1.04 |
3.44±0.83 |
-1.11 |
0.29 |
1.13 |
0.53 |
| |
4 weeks |
3.43±1.29 |
3.83±0.95 |
-0.72 |
0.49 |
0.29 |
0.60 |
| MAL(QOU) |
Baseline |
2.44±0.64 |
2.60±073 |
-0.47 |
0.64 |
|
|
| |
2 weeks |
2.92±1.04 |
3.44±0.83 |
-1.11 |
0.29 |
1.13 |
0.53 |
| |
4 weeks |
3.43±1.29 |
3.83±0.95 |
-0.72 |
0.49 |
0.29 |
0.60 |
|
